跳至主要内容
临床试验/EUCTR2007-003692-39-IT
EUCTR2007-003692-39-IT进行中(未招募)不适用

Evaluation of immunogenicity of 7-valent Pneumococcal Conjugate Vaccine (Prevenar) and Hexavalent DtPa-HBV-IPV-Hib (InfaNrix Hexa), co-administered at the same time, versus Hexavalent vaccine, used in primary immunization schedule - ND

AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA0 个研究点开始时间: 2007年7月12日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthy children >= 11 months of age, who received three doses of hexavalent vaccine (DtPa-HBV-IPV-Hib) or received three doses of hexavalent vaccine (DtPa-HBV-IPV-Hib) plus 7-valent Pneumococcal conjugate vaccine.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Any temporary condition which prevents the subject from drawing blood sample. Administration of immunosoppressants drugs or any confirmed or suspected immunosuppressive or immunodeficient condition. Administration of immunoglobulins and/or any blood products within the last three months. Participation in another investigational trial.

研究者

发起方
AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA

相似试验